Bastone Bronwen 4
4 · Enfusion, Inc. · Filed Jan 10, 2024
Insider Transaction Report
Form 4
Enfusion, Inc.ENFN
Bastone Bronwen
Chief People Officer
Transactions
- Sale
Class A Common Stock
2024-01-09$8.95/sh−410$3,669→ 153,846 total - Sale
Class A Common Stock
2024-01-08$9.23/sh−391$3,609→ 154,256 total
Footnotes (3)
- [F1]Consists of shares required by the Issuer to be sold by the Reporting Person to cover tax withholding obligations in connection with the issuance of the shares, and does not represent discretionary trades by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.17 to $9.34. Full information regarding the number of shares sold at each separate price will be furnished to the SEC staff upon request.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.82 to $9.11. Full information regarding the number of shares sold at each separate price will be furnished to the SEC staff upon request.